Menu
Back to Dove Press podcast topics » International Journal of Chronic Obstructive Pulmonary Disease » International Journal of COPD podcast series » Inhalation effort for COPD patients and why inhaler choice matters
Inhalation effort for COPD patients and why inhaler choice matters
Dr Richard Russell is joined by Professor Omar Usmani to discuss inhalation effort and the factors that influence drug delivery in patients with COPD. They will explain why inhaler choice is an important consideration and what patient characteristics to look out for when prescribing.1,2 Dr Russell will also delve into a newly released publication on fungal sensitisation and the impact this has on patients with COPD.3 Following this, he will highlight what people are talking about on social media regarding COVID-19 and COPD, including mask wearing and the effect of the pandemic on exacerbation rates.
1 Dekhuijzen PNR, et al. Respir Med 2013;107:1817–1821;
2 Usmani OS. Ther Clin Risk Manag 2019;15:461–472;
3 Tiew PY, et al. Eur Respir J 2020;56:2000418.
Disclosures
Professor Omar Usmani
Dr Omar Usmani reports research funding, advisory board attendance and symposium funding from Aerocrine, Almirall, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, Covis, Edmond Pharma, GlaxoSmithKline, Mundipharma, Napp, Novartis, Roche, Sandoz, Takeda, Trudell Medical, UCB and Vectura..
Bios:
 |
Professor Omar Usmani Professor Omar Usmani is Professor of Respiratory Medicine and Honorary Consultant Physician at the National Heart and Lung Institute, Imperial College London, Royal Brompton Hospital and St Mary’s Hospital London. He is Head of Assembly 5 (Airway Diseases, Asthma, COPD and Chronic Cough) at the European Respiratory Society (ERS), Vice President for Scientific Outputs of the Respiratory Effectiveness Group (REG), Chair of the UK Inhaler Group (UKIG), Vice-Chair of Drug Delivery to the Lungs (DDL) and President-elect of the International Society of Aerosols in Medicine (ISAM). In 2019, he was made a Fellow of the ERS. |
This series of podcasts are intended for healthcare professionals only.
The Medical Insider COPD podcast series discusses hot topics in the world of COPD with those who know it best, aiming to spread information, debunk myths and improve the lives of patients. The Editorial Board of the Medical Insider COPD podcast is comprised of Professor James Chalmers, the British Lung Foundation Chair of Respiratory Research at the University of Dundee (UK), Professor Michael Dreher, the Head of the Department of Pneumology and Intensive Care Medicine at the University Hospital Aachen (Germany), and the host and moderator, Dr Richard Russell, a Consultant Chest Physician at Lymington New Forest Hospital (UK), a Senior Clinical Researcher at the University of Oxford (UK) and the founding editor of the International Journal of COPD. These series of podcasts have not been peer-reviewed, but have been vetted by the journal’s Editor-in-Chief.
Copyright © 2021, Boehringer Ingelheim Group of Companies. All rights reserved.
Publish time: 23 December 2021
Episode number: 4
Duration: 23 minutes 36 seconds